Zheng Xifeng, Zeng Feng, Lei Yan, Li Yanling, Deng Jun, Luo Gengqiu, He Qian, Zhou Yanhong
Department of Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine Central South University/Hunan Cancer Hospital, Changsha, Hunan, China.
Cancer Research Institute, Basic School of Medicine, Central South University, Changsha, Hunan, China.
Front Oncol. 2025 Jul 29;15:1635209. doi: 10.3389/fonc.2025.1635209. eCollection 2025.
YBX1 is a member of the Y-box transcription factor family and is a multifunctional RNA/DNA-binding protein characterized by a highly conserved cold shock domain (CSD). YBX1 is localized in both the cytoplasm and nucleus, where it participates in various biological processes such as transcription, translation, and DNA damage repair. YBX1 is upregulated in numerous malignant tumors and is closely associated with tumor progression and poor prognosis, making it a recognized target for cancer therapy. This review introduces the role and mechanism of YBX1 in tumor progression, its function in embryonic development, bone differentiation, cartilage formation, and adipogenesis, the impact of upstream regulatory factors on its function, as well as the relationship between YBX1 and disease prognosis and treatment outcomes. This review aims to provide a comprehensive perspective on the function of YBX1.
YBX1是Y盒转录因子家族的成员,是一种多功能RNA/DNA结合蛋白,其特征在于高度保守的冷休克结构域(CSD)。YBX1定位于细胞质和细胞核中,在其中参与各种生物学过程,如转录、翻译和DNA损伤修复。YBX1在许多恶性肿瘤中上调,并且与肿瘤进展和不良预后密切相关,使其成为公认的癌症治疗靶点。本综述介绍了YBX1在肿瘤进展中的作用和机制、其在胚胎发育、骨分化、软骨形成和脂肪生成中的功能、上游调节因子对其功能的影响,以及YBX1与疾病预后和治疗结果之间的关系。本综述旨在提供关于YBX1功能的全面观点。